Organization update: Nicole Lambert, COO, retiring October 5, 2023 Teammates, It's with truly bittersweet feelings that I share the news today that Nicole Lambert, our Chief Operating Officer, will be retiring from full-tim... Continue Reading
Have You Ever Thought About the People Behind Your Lab Results? Now’s the Time! April 27, 2023 In honor of Medical Laboratory Professionals Week, taking place April 23 to April 29 this year, we are celebrating our teammates responsible for every clinical... Continue Reading
Better health through genetic insights – for everyone September 26, 2022 Shaping the future of precision medicine with greater access, ease of use, collaboration and innovation From Modern Healthcare Paul J. Diaz is president ... Continue Reading
The Future of Genetic Testing: How a Love of DNA Led to More Comprehensive Tests April 23, 2022 For more than 30 years now, scientists at Myriad Genetics have been finding creative ways to coax new information out of human genes. The love for exploring th... Continue Reading
April 14, 2022 Dear Stakeholders, In 2021, during the most difficult operating environment any of us has ever seen, Myriad Genetics executed a bold transformatio... Continue Reading
Inside One of the World’s Most Innovative Companies March 8, 2022 In March 2022, Myriad Genetics was named one of the World’s Most Innovative Companies by Fast Company. Since 2008, Fast Company’s Most Innovative Comp... Continue Reading
The Year Ahead: Innovating and Growing in 2022 and Beyond January 25, 2022 Eighteen months ago, we launched a bold transformation and growth plan for Myriad Genetics. The plan involved change in virtually every part of our business. On... Continue Reading
Mid-year Message August 18, 2021 Our mission of advancing health and well-being for all is meaningful. We've accomplished a lot so far this year, and I wanted to highlight some of it. I am prou... Continue Reading
Myriad Genetics Recognizes Three Distinguished Directors for 55 Years of Combined Board Service December 10, 2020 At the December meeting of its Board of Directors, Myriad Genetics recognized the meaningful contributions of three retiring board members -- Walter Gilbert, Jo... Continue Reading
Myriad Corporate Statement June 9, 2020 We are heartbroken over the systemic discrimination and racism that have persisted in this nation for too long. We have been quiet in reflection but believe tha... Continue Reading
A Letter from Bryan Riggsbee March 16, 2020 March 16, 2020 Dear Customer, At Myriad, we are actively monitoring the COVID-19/Coronavirus situation and have implemented a business continuity plan to ensu... Continue Reading
Myriad Genetics 2020 Facts at a Glance February 5, 2020 Myriad Genetics has been in business for almost 30 years and we are a global leader in precision medicine. Click on the image below to download our midyea... Continue Reading
Myriad Genetics 2019 Facts at a Glance February 8, 2019 Myriad Genetics has been in business for more than 27 years and we are a global leader in personalized medicine. Click on the image below to download our ... Continue Reading
BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer January 23, 2018 The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastat... Continue Reading
Myriad Partners with Project BioEYES to Improve STEM Education July 13, 2017 Myriad Genetics was proud to support Project BioEYES and help deliver STEM (science, technology, engineering, and mathematics) education to K-12 students thro... Continue Reading